Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-05-06 @ 4:31 PM
Study NCT ID:
NCT00082433
Status:
COMPLETED
Last Update Posted:
2020-11-02
First Post:
2004-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Sponsor:
R-Pharm
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA163-048
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Study Director
Old Organization:
Bristol-Myers Squibb